1. The expanding role of MRI in prostate cancer
- Author
-
Sangeet Ghai, Gillian Murphy, Boraiah Sreeharsha, and Masoom A. Haider
- Subjects
In vivo magnetic resonance spectroscopy ,Male ,medicine.medical_specialty ,Prostate biopsy ,Magnetic Resonance Spectroscopy ,Biopsy ,Patient Care Planning ,Prostate cancer ,Image Interpretation, Computer-Assisted ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Radiation treatment planning ,Neoplasm Staging ,medicine.diagnostic_test ,business.industry ,Multiparametric MRI ,Prostatic Neoplasms ,Magnetic resonance imaging ,General Medicine ,medicine.disease ,Magnetic Resonance Imaging ,Diffusion Magnetic Resonance Imaging ,Neoplasm staging ,Radiology ,business - Abstract
OBJECTIVE. The purpose of this article is to review the many evolving facets of MRI in the evaluation of prostate cancer. We will discuss the roles of multiparametric MRI, including diffusion-weighted MRI, dynamic contrast-enhanced MRI, and MR spectroscopy, as adjuncts to morphologic T2-weighted imaging in detection, staging, treatment planning, and surveillance of prostate cancer. CONCLUSION. Radiologists need to understand the advantages, limitations, and potential pitfalls of the different sequences to provide optimal assessment of prostate cancer.
- Published
- 2013